Holen Sie sich die Stockscreener-App
7.177
0.10%
-0.00301
Schlusskurs vom Vortag:
$7.18
Offen:
$7.17
24-Stunden-Volumen:
6.99M
Relative Volume:
0.68
Marktkapitalisierung:
$2.65B
Einnahmen:
$3.49M
Nettoeinkommen (Verlust:
$-663.48M
KGV:
-3.2059
EPS:
-2.2387
Netto-Cashflow:
$-115.08M
1W Leistung:
-0.24%
1M Leistung:
+35.59%
6M Leistung:
+83.92%
1J Leistung:
+100.92%
1-Tages-Spanne:
$7.16
$7.195
1-Wochen-Bereich:
$7.13
$7.21
52-Wochen-Spanne:
$3.06
$7.22
Ataibeckley Inc Stock (ATAI) Company Profile
Firmenname
Ataibeckley Inc
Sektor
Branche
Telefon
1 929 207 2670
Adresse
C/O ATAI LIFE SCIENCES US, INC., NEW YORK
Compare ATAI vs VRTX, REGN, ARGX, RVMD, ALNY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
7.175 | 2.66B | 3.49M | -663.48M | -115.08M | -2.2387 |
VRTX
Vertex Pharmaceuticals Inc
|
480.75 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
673.21 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
898.28 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.05 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.11 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | Deutsche Bank | Buy |
| 2026-01-20 | Eingeleitet | Guggenheim | Buy |
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-07-29 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-18 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-03 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
| 2021-11-11 | Eingeleitet | ROTH Capital | Buy |
| 2021-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-01 | Eingeleitet | Jefferies | Buy |
| 2021-07-13 | Eingeleitet | Berenberg | Buy |
| 2021-07-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-13 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-07-13 | Eingeleitet | Cowen | Outperform |
| 2021-07-13 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Ataibeckley Inc Aktie (ATAI) Neueste Nachrichten
Tracking Cathie Wood: Slashing AtaiBeckley and Figma, Betting on Gene-Editor Scribe Therapeutics - Moomoo
ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too? - Stocktwits
Why Is ATAI Stock Soaring 59% After-Hours? - Stocktwits
AtaiBeckley Inc. Revenue Breakdown – MUN:B72 - TradingView
AtaiBeckley Inc. Revenue Breakdown – FWB:B72 - TradingView
ATAI Stock Eyes Rocketing Back To 4-Year Highs: VC Sees Up to 105% Takeover Premium From Eli Lilly - Stocktwits
AtaiBeckley Inc. Revenue Breakdown – LS:A41WEP - TradingView
Why Did AAPL, ATAI, UNH Stocks Jump To 52-Week Highs Today? - Stocktwits
Is AtaiBeckley (ATAI) A Bargain On Eli Lilly’s Takeover Deal? - simplywall.st
AtaiBeckley Inc. (ATAI) stock price, news, quote and history - Yahoo Finance UK
Form DEF 14A ATAI Beckley Inc For: 23 July By Investing.com - Investing.com Canada
How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33% - Yahoo Finance
Key facts: Zepbound tops Wegovy; Novo sues; Lilly buys AtaiBeckley - TradingView
Lilly-AtaiBeckley Deal A Stamp Of Approval For Psychedelics - Law360
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? - TradingView
H.C. Wainwright downgrades AtaiBeckley stock rating on Lilly deal By Investing.com - Investing.com India
H.C. Wainwright downgrades AtaiBeckley stock rating on Lilly deal - Investing.com UK
Tracking Cathie Wood: Backing Prime Medicine and SpaceX, Sells Off AtaiBeckley, Shopify - Moomoo
Eli Lilly Acquires AtaiBeckley to Expand Mental Health Treatment Pipeline in $3.8 Billion Deal - Global Legal Chronicle
AtaiBeckley (NASDAQ:ATAI) shares reflect 18% implied value for acquisition milestone entitlements - TechStock²
ATAIBECKLEY INC : BERENBERG CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $7.45 FROM $14 - Bitget
AtaiBeckley (ATAI) H.C. Wainwright 26th Annual Global Investment Conference 2024 summary - Quartr
ATAIBECKLEY INC : TD COWEN CUTS TO HOLD FROM BUY - Bitget
H.C. Wainwright Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.5 - Moomoo
J&J, AbbVie said to have also looked at AtaiBeckley before Lilly’s $2.8B deal - Endpoints News
ATAI Stock Downgraded Across Wall Street – Why Analysts Believe Buyout By Eli Lilly Capped Near-Term Upside - TradingView
Berenberg Downgrades AtaiBeckley to Hold From Buy, Adjusts Price Target to $7.45 From $14 - Moomoo
TD Cowen Downgrades AtaiBeckley to Hold From Buy - marketscreener.com
Lilly Joins Psychedelic Drug Race With AtaiBeckley Buyout – Merger Arbitrage Mondays (NASDAQ:ATAI) - Seeking Alpha
Weekly Recap: Eli Lilly acquisition of AtaiBeckley and BPL-003 Phase 3 - TradingView
ATAI Stock Slips After Blockbuster Week: Cathie Wood Calls $3.8B Lilly Deal ‘Well-Deserved’ Return For Shareholders - TradingView
Why Did ATAI, PANW, TRV Stocks Surge To 52-Week Highs Last Week? - Yahoo Finance
AtaiBeckley (NASDAQ:ATAI) shares trade with Merger CVR valued near 19% of face - TechStock²
Eli Lilly (LLY) to Acquire AtaiBeckley for $2.8B - GuruFocus
Berenberg Bank Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI) - The Globe and Mail
Maxim Group Maintains AtaiBeckley(ATAI.US) With Hold Rating - Moomoo
Eli Lilly psikedelik ilaç üreticisi AtaiBeckley’yi 2,8 milyar dolara satın alıyor; zihinsel hastalık tedavilerinde yeni seçeneklerin devreye girmesi bu satın almanın gündeme gelmesinde önemli bir etken. Bu satın almayla Lilly, AtaiBeckley’nin deneysel DMT bazlı ila - instagram.com
TD Cowen Downgrades AtaiBeckley(ATAI.US) to Hold Rating - Moomoo
Form 13D/A AtaiBeckley Inc. For: 17 July By Investing.com - Investing.com Canada
AtaiBeckley Inc. (NASDAQ: ATAI) investor commits 15.4% stake to Lilly deal - Stock Titan
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc.ATAI - Business Wire
Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion - Benzinga
A Quick Look at Today's Ratings for AtaiBeckley(ATAI.US), With a Forecast Between $7.5 to $8 - Moomoo
Eli Lilly Expands with $2.8B Psychedelic Acquisition - Investing News Network
Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout - TradingView
Eli Lilly Drops $3.8 Billion on AtaiBeckley, Sending Psychedelic Stocks Soaring - finance.biggo.com
This ONEOK Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - Benzinga
Eli Lilly agrees to $3.8B psychedelic buy - Axios
Biotech Growth says Eli Lilly's $2.8bn swoop on AtaiBeckley underlines the value of smaller drug developers - QuotedData
Lilly to buy AtaiBeckley in $3.8B psychedelic push - MSN
Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time - TradingView
Finanzdaten der Ataibeckley Inc-Aktie (ATAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):